Evaluation of E-cadherin, β-catenin and vimentin protein expression using quantitative immunohistochemistry in nasopharyngeal carcinoma patients Abstract Purpose: Aberrant expression of proteins involved in epithelial-to-mesenchymal transition have been described in various cancers. In this retrospective study, we sought to evaluate E-cadherin, β-catenin and vimentin protein expression in non-metastatic nasopharyngeal (NPC) patients treated with curative intent, examine their relationship with each other, and with clinical outcome measures.Methods: Pre-treatment formalin-fixed paraffin-embedded biopsies of 140 patients treated between January 2000 and December 2007 were assembled into a tissue microarray (TMA). Automated quantitative immunohistochemistry (AQUA®) was performed on sequential TMA sections stained with fluorescent-labeled antibodies against E-cadherin, β-catenin and vimentin. Cox proportional hazards regression was used to estimate the effect of cytoplasmic vimentin, cytoplasmic E-cadherin, β-catenin nuclear/cytoplasmic ratio expression on overall survival and disease-free survival.Results: The average age of the patients was 51.7 years (SD=12.1; range 18-85), 66% were male, 71% had a KPS ≥ 90% at the start of treatment and 65% had stage III/IV disease. After adjusting for performance status, WHO and stage, high E-cadherin levels over the 75th percentile were found to produce a significantly increased risk for both a worse overall survival (HR = 2.53, 95% CI 1.21, 5.27) and disease free survival (DFS; HR = 2.14, 95%CI 1.28, 3.59). Vimentin levels over the first quartile produced an increased risk for a worse DFS (HR = 2.21, 95% CI 1.11, 4.38). No association was seen between β-catenin and survival.Conclusion: In this cohort of NPC patients, higher levels of E-cadherin and higher levels of vimentin were associated with worse outcomes. Further work is needed to understand the role of these epithelial mesenchymal transition proteins in NPC. Since nasopharyngeal cancers (NPC) commonly invade surrounding tissue or metastasize to cervical lymph nodes early in the natural history of the disease, we sought to characterize the protein expression of E-cadherin, β-catenin and vimentin, three proteins involved in EMT, in non-metastatic NPC patients treated with curative intent. We explored the relationship among E-cadherin, β-catenin and vimentin, and their relationship with clinical outcome measures. curative intent radiation ± platinum chemotherapy at British Columbia Cancer Agency and Tom Baker Cancer Centre were identified with retrievable biopsy samples, either from the primary site or from a nodal metastasis. Tissue microarrays (TMAs) were constructed from duplicate 0.6 mm cores of pretreatment formalin-fixed paraffin-embedded specimens. Fluorescent immunohistochemistry was performed on sequential TMA sections that were co-stained with antibodies against Ecadherin (1:200, Rabbit clone 24E10, Cell Signaling, Danvers, MA) or β-catenin (1:1000 mouse clone B-cat-1, Dako Cytomation, Glostrup, Denmark) and vime...